Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

J. CHUCK HARRELL, PhD

Virginia Commonwealth University

Genomic Dissection of Patient-Derived Xenograft Breast Cancer Liver Metastasis Models

MARK HEADLEY, PhD

Fred Hutchinson Cancer Research Center

Monocyte Contribution To Lung Metastasis Of Breast Cancer

Blake “Eason” Hildreth, DVM, MS, PhD

University of Alabama, Birmingham

Targeting the CSF1R/PU.1 axis and PU.1/BET super-enhancer regulome in breast cancer bone metastasis

Daniel Hollern, PhD, BS

The Salk Institute for Biological Studies

Presented by The Orlando Metsquerade in memory of Caitlin Kosma, wife, mother, friend and advocate

Using B cells to eliminate TNBC liver metastases

Erin Howe, PhD

University of Notre Dame-Harper Cancer Research Institute

Presented in memory of Erin Remme by Minneapolis Metsquerade

Targeting endosomal trafficking to enhance immune recognition of breast cancer brain metastases

Quanyin HU, PhD

School of Pharmacy, University of Wisconsin-Madison

Presented In memory of Andi Myers and Elizabeth Seagraves Murray and those from the support group “Living with MBC in DENJPA”

Targeted degradation of BET proteins in combination with immune checkpoint inhibitors for treating metastatic triple-negative breast cancer

MENGYING HU, PHD

The Ohio State University

Improving anti-PD1 efficacy by activated T cell-derived EVoids in metastatic breast cancer

Barry Hudson, PhD

University of Miami

Presented in memory of Amanda De Fiebre by Southwest Florida Metsquerade

Therapeutic targeting of RAGE in metastatic breast cancer

Natasha Hunter, MD

University of Washington

Presented by Metavivor Facebook Fundraisers

Tissue and liquid biopsy for breast cancer patients with bone-only metastases

Douglas Hurst, PhD

University of Alabama at Birmingham, Alabama

Improving oncolytic herpes simplex virus for metastatic breast cancer

DOUGLAS HURST, Ph.D.

University of Alabama at Birmingham, Alabama

Improving oncolytic herpes simplex virus for metastatic breast cancer

Fumito Ito, MD, PhD

Roswell Park Comprehensive Cancer Center Health Research Inc

Presented by Southwest Florida Metsquerade in Memory of Karin Petrocelli

In situ radio-immunotherapy to maximize the engagement of cross-presenting dendritic cells to treat metastatic breast cancer